Macter profit rises 8% on strong sales growth

Mettis Global reported that Macter International earned Rs529.30 million for the nine months ended March 31, 2026, an 8.44% rise from Rs488.10 million in the same period last year. Earnings per share moved to Rs11.50 from Rs10.64, an increase of 8.08%. The pharmaceutical company's net profit gain came despite a sharp increase in income tax.

Net revenue climbed 21% to Rs9.27 billion from Rs7.68 billion, while gross profit rose 29% to Rs4.51 billion. Selling and distribution costs grew 31% to Rs2.74 billion, and administrative expenses went up 36% to Rs679.13 million. Other income fell 41% to Rs36.65 million, although a 77% drop in the charge on loss allowance on trade debts eased costs.

Operating profit increased 19% to Rs1.04 billion, and profit before tax rose 21% to Rs942.76 million. Finance costs were little changed at Rs99.32 million, while taxation surged 43% to Rs413.46 million, which absorbed much of the pre-tax gain.